高效液相色谱法测定血管紧张素转化酶抑制剂的活性

建立了体外直接测定血管紧张素转化酶抑制剂活性的高效液相色谱分析方法。以马尿酰-组氨酰-亮氨酸为反应底物,血管紧张素转化酶为催化剂,反应所生成的马尿酸为测定指标,未加酶抑制剂的反应为空白对照。使用ZORBAX SB-C18色谱柱(4.6 mm i.d.×150 mm,填料粒径5　μm),柱温25 ℃,流动相为乙腈-超纯水(体积比为25∶75,各含0.05%（体积分数）三氟乙酸及0.1%（体积分数）三乙胺),流速0.5 mL/min,检测波长228 nm。在马尿酸浓度为0.005～1.000 mmol/L时,马尿酸浓度与其峰面积呈良好的线性关系(r＝0.9999),最小检测限为0.50 μmol/L;该方法对马尿酸的回收率为99.48%～105.64%,相对标准偏差(RSD)为2.20%(n＝6)。该方法可适用于血管紧张素转化酶抑制剂活性的体外测定,具有操作简便、精密度和准确性高的特点,为降血压药物的研制提供了方便可靠的检测手段。     

亲和色谱法筛选中药中血管紧张素转化酶抑制剂

以壳聚糖微球为载体、戊二醛（glutaraldehyde,GA）为交联剂对血管紧张素转化酶（Angiotensin converting enzyme,ACE）进行固定化．用固化的ACE作为亲和介质,利用血管紧张素转化酶抑制剂（Angiotensin convertingenzym einhibitor,ACEI）与ACE之间的亲和作用,结合高效液相色谱对亲和前后的体系进行检测,比较两者各组分色谱峰的差异,以此实现快速筛选复杂体系中的ACE抑制剂．应用赖诺普利（Lisinopril）、九肽抑制剂、依那普利（Enalapril）、培哚普利（Perindopril）、卡托普利（Captopril）等已上市的ACEI对方法进行验证,反映方法具有高度选择性．将方法应用于中药地龙及山楂筛选,发现共有5个组分与ACE有亲和作用,并且都能抑制ACE酶活性,它们对酶活性抑制的IC50值在0．45～4．62μg／mL范围．通过对亲和方法重现性考察,6次测定的相对标准偏差小于1％,说明方法可靠．提出的亲和色谱．色谱指纹差异法非常适合于从中药及天然产物等复杂混合物库中快速筛选靶点活性物质．     

类蛋白反应修饰海地瓜酶解物及ACE抑制肽的制备

采用类蛋白反应修饰海地瓜体壁蛋白酶解物,制得修饰肽的血管紧张素转换酶(ACE)抑制活性与原酶解液的活性相比显著提高;模拟消化实验结果表明,修饰肽与胃肠蛋白酶作用后可增强其降压活性;细胞毒性实验结果表明,样品浓度在低于10 mg/mL时对犬肾细胞(MDCK)无毒性,且低浓度可以促进细胞生长.采用超滤、Sephadex G-15凝胶柱层析和RP-HPLC等分离技术纯化修饰产物,得到高活性ACE抑制肽(IC50值为3.67μmol/L),序列结构为NQNFVQYTTNT.紫外光谱分析结果表明,修饰肽与ACE结合可引起吸光度变化.用SYBYL软件对抑制肽与ACE活性位点进行模拟对接,发现该抑制肽能与ACE很好地结合.     

溶剂诱导相变萃取-分光光度法测定血管紧张素转化酶活性

在传统体外测定血管紧张素转化酶(ACE)活性方法的基础上, 以猪肺ACE粗提物为酶源, 采用溶剂诱导相变萃取法(SIPSE)萃取酶反应产物马尿酸(HA), 用分光光度法快速定量测定HA以评估ACE活性或样品对ACE的抑制活性. 以卡托普利为模型验证了此方法, 并分别测定了中药复方天麻钩藤饮及其含有的11味中药对ACE的抑制活性. 结果表明, 猪肺ACE粗提物即可满足ACE抑制活性测定的需要; 与传统液液萃取法相比, SIPSE对HA具有更高的选择性及萃取能力, 萃取率为(97.47±0.55)%(n=3); 通过计算校正, 溶剂诱导相变萃取-分光光度法能简便、 快速且准确地测定成分复杂体系的ACE抑制活性.     

高效液相色谱分离纯化血管紧张素转换酶活性抑制肽

采用分步高效液相色谱法首次从菠菜核酮糖双磷酸羧化酶(英文缩写为Rubisco)的胃蛋白酶-胰酶复合酶水解产物中分离纯化了血管紧张素转换酶(ACE)活性抑制肽。水解产物经ODS柱分离得到活性组分,这些活性组分再依次经过氨基柱(PhA) 氰基柱(CN)和硝基苯乙基柱(NPE)4种色谱柱分离后,得到4种高度纯化的具有抑制ACE活性的多肽。经蛋白质序列自动分析仪测定,4种多肽的结构分别为MRWRD,MRW,IAYKPAG和LRIPVA。采用固相多肽合成法分别合成了这4种肽,并采用测定ACE活性抑制率的方法评价其     

血管紧张素转化酶活性抑制剂──丝素肽的分离、纯化和结构鉴定

 可溶性丝素粉末经碱性蛋白酶Alcalase水解后 ,其酶解产物对血管紧张素转化酶 (ACE)的活性有很强的抑制作用。采用凝胶过滤色谱SephadexG 15和反相高效液相色谱 (RP HPLC)对水解度为 2 0 %的酶解产物进行分离纯化 ,利用质谱鉴定其中一种ACE抑制剂是肽 ,其结构为Gly Tyr。     

基于反相液相色谱-串联质谱的鹿茸模拟胃肠道消化的肽谱及生物活性研究

利用反相液相色谱-串联质谱(Reversed phase liquid chromatography-tandem mass spectrometry,RPLCMS/MS)对鹿茸蛋白经过模拟消化的肽谱进行分析,同时考察了消化产物的体外活性。从鹿茸水提物(Antler aqueous extract,AAE)、鹿茸水提物消化产物(Aqueous extract digest,AED)和鹿茸的粉末消化产物(Powder digest,PD)中分别鉴定到23、417和389条肽段,其中源于胶原蛋白的肽分别有15、146和75条。以血管紧张素转换酶(Angiotensin converting enzyme,ACE)、二肽基肽酶IV(Dipeptidyl peptidase IV,DPP-IV)、脯氨酰内切酶(Prolyl endopeptidase,PEP)抑制活性和抗氧化活性为指标考察AAE、AED和PD的体外生物活性,发现其活性强弱关系为AAEAEDPD。结果表明,经过模拟消化后,AED释放出更丰富的胶原蛋白肽,而PD具有更好的生物活性,说明食用鹿茸粉末和鹿茸水提物互为补充,各具优势。     

基质辅助激光解吸电离飞行时间串联质谱法分析人乳β-酪蛋白新生儿体外消化模型多肽组

通过体外模拟新生儿消化道条件,用基质辅助激光解吸离子化飞行时间串联质谱法(MALDI-TOF/TOF)探究人乳β-酪蛋白消化后的多肽组.在离子源加速电压为20 kV,激光波长337 nm,激光频率200 Hz,离子延迟提取时间330 ns,质谱信号单次扫描累加2000次条件下,扫描质量范围m/z 500 ～ 5000的肽段.结果表明,消化后得到26个肽段,分子量集中在1000～4000Da.与已知功能的肽段序列进行对比,人乳β-酪蛋白在新生儿体外模型消化后未产生与已知功能的活性肽序列匹配的肽段,但发现9个肽前体,其中含4个血管紧张素转化酶(ACE)抑制肽前体,2个酪蛋白磷酸肽(CPP)前体,2个抗氧化肽前体,1个免疫活性肽前体,由酶切位点推测分析,肽前体可以继续在蛋白酶作用下转化为生物活性肽.     

毛细管胶束电动色谱法测定血管紧张素转化酶的活性

 建立了应用毛细管胶束电动色谱 (MECC)灵敏、快速的测定血管紧张素转化酶 (ACE)活性的方法。通过对电压、上样时间、电极缓冲液体系等影响因素的优化 ,探讨了方法的可行性 ,确立了最佳测定条件 (电压 :8 1kV ;上样时间 :1s;电极缓冲液 :2 0mmol/L硼酸盐缓冲液 (pH 9 0 ,含 5 0mmol/LSDS) ;检测波长 :2 2 8nm)。方法的最低ACE活性检测限为 5pmol/min(以 2倍的信噪比计 )。     

神经网络在ACE抑制肽QSAR中的应用研

通过对天然氨基酸的457种物化性质参数进行主成分分析后得到SVHEHS描述符,用该描述符分别对血管紧张素转化酶(ACE)抑制二肽、三肽、四肽进行表征,并建立了肽结构与活性的神经网络模型。ACE抑制二肽神经网络模型的相关系数、交叉验证相关系数、均方根误差和外部验证相关系数分别为0.946、0.951、0.249、0.852,三肽模型分别为0.973、0.945、0.135、0.813,四肽模型分别为0.915、0.879、0.250、0.814。由此表明SVHEHS描述符结合神经网络对ACE抑制肽的建模效果及模型预测能力均较理想,在此基础上进一步通过平均影响值(Mean impact value,MIV)法确定了显著影响各类肽活性的结构因素,从而为新的强活性ACE抑制肽的分子设计提供了理论基础。     

新型血管紧张素转化酶抑制剂: 氮杂三肽类似物的合成及结构活性关系

设计与合成一系列氮杂三肽类似物, 测定了氮杂三肽类似物对血管紧张素转化酶的体外抑制活性, 探讨了它们的结构与抑制活性之间的关系, 结果表明氮杂丙氨酸是丙氨酸很好的替代物。     

Activity of angiotensin-converting enzyme inhibitors in venoms of central Asian snakes

The inhibition of angiotensin-converting enzyme (ACE, K.F.3.4.15.1) by low-molecular-weight fractions of venoms from central Asian snakes was studied using N-(3-[2-furyl]acryloyl)-Phe-Gly-Gly (FAPGG) as substrate. Their activity is substantial in peptide fractions of poisons from snakes of the Viperidae and Crotalidae families and completely absent in cobra poison (Elapidae).Institute of Biochemistry, Academy of Sciences of the Republic of Uzbekistan, Tashkent, fax (99871) 162 32 56. Translated from Khimiya Prirodnykh Soedinenii, No. 3, pp. 254–256, May–June, 2000.     

Antioxidant activity of peptide-based angiotensin converting enzyme inhibitors

Angiotensin converting enzyme (ACE) inhibitors are important for the treatment of hypertension as they can decrease the formation of vasopressor hormone angiotensin II (Ang II) and elevate the levels of vasodilating hormone bradykinin. It is observed that bradykinin contains a Ser-Pro-Phe motif near the site of hydrolysis. The selenium analogues of captopril represent a novel class of ACE inhibitors as they also exhibit significant antioxidant activity. In this study, several di- and tripeptides containing selenocysteine and cysteine residues at the N-terminal were synthesized. Hydrolysis of angiotensin I (Ang I) to Ang II by ACE was studied in the presence of these peptides. It is observed that the introduction of L-Phe to Sec-Pro and Cys-Pro peptides significantly increases the ACE inhibitory activity. On the other hand, the introduction of L-Val or L-Ala decreases the inhibitory potency of the parent compounds. The presence of an L-Pro moiety in captopril analogues appears to be important for ACE inhibition as the replacement of L-Pro by L-piperidine 2-carboxylic acid decreases the ACE inhibition. The synthetic peptides were also tested for their ability to scavenge peroxynitrite (PN) and to exhibit glutathione peroxidase (GPx)-like activity. All the selenium-containing peptides exhibited good PN-scavenging and GPx activities.     

Studies on angiotensin converting enzyme inhibitors. VI. Synthesis and angiotensin converting enzyme inhibitory activities of the dicarboxylic acid derivative of imidapril and its diastereoisomers.

All possible diastereoisomers of the dicarboxylic acid (10a), the biologically active form of imidapril (1), were synthesized, and their inhibitory activity against angiotensin converting enzyme (ACE) was examined. The in vitro ACE inhibitory activity of these compounds greatly depended on the configurations of the three asymmetric carbons in each molecule. The (S,S,S) isomer (10a) showed much more potent activity than the others.     

反相液相色谱-串联质谱法鉴定油菜蜂花粉中的蛋白质及活性肽

基于鸟枪法蛋白质组学分析方法,使用反相液相色谱-串联质谱（RPLC-MS/MS）系统分析油菜蜂花粉蛋白质的胰蛋白酶酶解产物,结合数据库检索,共鉴定到353条肽段。鉴定到的肽段所归属的蛋白质中有239个蛋白质可检索到其分子生物学功能,主要功能为结合活性、酶活性、运输活性、抑制活性等。根据血管紧张素转化酶（ACE）抑制肽活性与多肽构效之间的关系,从鉴定到的肽段中筛选并适当修饰后得到5条可能具有ACE抑制活性的肽段,化学合成肽段后进行了活性验证。结果表明5条肽段均具有良好的活性,其中肽段AELDIVLALF和LAVNLIPFP表现出较高的ACE抑制活性,半数抑制浓度（IC₅₀）分别为（10.65±0.50）μmol/L和（23.66±1.08）μmol/L。该方法速度快,成本低,大大缩短了鉴定周期,达到了高通量筛选生物活性肽的目的。     

Analysis method of the angiotensin-I converting enzyme inhibitory activity based on micellar electrokinetic chromatography.

A micellar electrokinetic chromatography (MEKC) method was developed for estimating the angiotensin-I converting enzyme (ACE) inhibitory activity by separating the hippuric acid liberated in the ACE reaction mixture in the presence of an inhibitor, captopril. The hippuric acid was successfully separated and detected by MEKC with a 25 mM sodium dodecyl sulfate solution in a 25 mM phosphate-50 mM borate buffer at pH 7.0; the total analysis took about 5 min. A good linear relationship was observed between the inhibitor and the peak area of hippuric acid release. No significant difference in the ACE inhibitory activity (IC50) of captopril (an antihypertensive medicine) or autolyzed-mushrooms (functional foods) was observed between the conventional method and the MEKC method. The MEKC method was found to be a useful technique for a rapid assay of the ACE inhibitory activity.     

Pharmacophore-based structure optimization of angiotensin converting enzyme inhibitory peptide

Chemical feature based pharmacophore models were generated for an angiotensin converting enzyme(ACE) inhibitory peptide using the Discovery Studio 2.0 pharmacophore modeling approach. The pharmacophore hypothesis selected has five features(one negative ionizable region,one hydrogen bond donor,one hydrogen bond acceptor and two hydrophobic functional groups). Additionally,ACE inhibitory hexapeptide previously obtained from silkworm pupae protein was optimized to target the ACE based on the selected pharmacophore. The results suggest that tri-peptide(thr-val-phe) may be structural determinant of ACE activity. Docking studies further provided confidence for the validity of the selected pharmacophore model to perform structure optimization of the ACE inhibitory peptide.     

高活性燕麦蛋白源ACE抑制肽的制备、纯化及结构鉴定

利用胰蛋白酶水解燕麦蛋白制备了高血管紧张素转化酶(Angiotensin I-Converting Enzyme, ACE)抑制活性的燕麦蛋白酶解物, 分别采用离子交换色谱、凝胶过滤色谱和反相高效液相色谱等分离手段从酶解物中分离出一种新的强活性ACE抑制肽, 其IC50值为77.3 μmol/L; 通过基质辅助激光解析电离飞行时间串联质谱对其进行结构鉴定, 其氨基酸序列为Glu-Gly-Gly-Tyr-Arg.